160 related articles for article (PubMed ID: 30166568)
1. A novel, non-invasive model for diagnosing liver fibrosis stage in patients with hepatocellular carcinoma.
Ouyang GX; Zhang YM; Zhu SL; Wang P; Ren Y; Li JH; Liu YK; Chen J; Xiang BD; Li LQ; Liu JY; Zhang ZM
Sci Rep; 2018 Aug; 8(1):13074. PubMed ID: 30166568
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy of APRI and FIB-4 for predicting hepatitis B virus-related liver fibrosis accompanied with hepatocellular carcinoma.
Xiao G; Zhu F; Wang M; Zhang H; Ye D; Yang J; Jiang L; Liu C; Yan L; Qin R
Dig Liver Dis; 2016 Oct; 48(10):1220-6. PubMed ID: 27599803
[TBL] [Abstract][Full Text] [Related]
3. Spleen to non-cancerous liver volume ratio predicts liver cirrhosis in hepatocellular carcinoma patients.
Geng Y; Shao WQ; Lin J
Abdom Radiol (NY); 2023 Feb; 48(2):543-553. PubMed ID: 36380210
[TBL] [Abstract][Full Text] [Related]
4. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
Li Q; Li W; Huang Y; Chen L
J Viral Hepat; 2016 Nov; 23(11):912-919. PubMed ID: 27375134
[TBL] [Abstract][Full Text] [Related]
5. Platelet count to spleen diameter ratio non-invasively identifies severe fibrosis and cirrhosis in patients with autoimmune hepatitis.
Sheptulina A; Shirokova E; Nekrasova T; Blum H; Ivashkin V
J Gastroenterol Hepatol; 2016 Dec; 31(12):1956-1962. PubMed ID: 27059170
[TBL] [Abstract][Full Text] [Related]
6. Fibrosis-4, aspartate transaminase-to-platelet ratio index, and gamma-glutamyl transpeptidase-to-platelet ratio for risk assessment of hepatocellular carcinoma in chronic hepatitis B patients: comparison with liver biopsy.
Kim MN; Lee JH; Chon YE; Ha Y; Hwang SG
Eur J Gastroenterol Hepatol; 2020 Mar; 32(3):433-439. PubMed ID: 31490417
[TBL] [Abstract][Full Text] [Related]
7. The FIB-4 index is a significant prognostic factor in patients with non-B non-C hepatocellular carcinoma after curative surgery.
Okamura Y; Ashida R; Yamamoto Y; Ito T; Sugiura T; Bekku E; Aramaki T; Uesaka K
Langenbecks Arch Surg; 2016 Mar; 401(2):195-203. PubMed ID: 26943655
[TBL] [Abstract][Full Text] [Related]
8. Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B.
Hu YC; Liu H; Liu XY; Ma LN; Guan YH; Luo X; Ding XC
World J Gastroenterol; 2017 Nov; 23(41):7425-7432. PubMed ID: 29151696
[TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of GPR versus APRI and FIB-4 in predicting different levels of liver fibrosis of chronic hepatitis B.
Liu DP; Lu W; Zhang ZQ; Wang YB; Ding RR; Zhou XL; Huang D; Li XF
J Viral Hepat; 2018 May; 25(5):581-589. PubMed ID: 29230907
[TBL] [Abstract][Full Text] [Related]
10. The gamma-glutamyl transpeptidase to platelet ratio for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease.
Li Q; Lu C; Li W; Huang Y; Chen L
Oncotarget; 2017 Apr; 8(17):28641-28649. PubMed ID: 28415736
[TBL] [Abstract][Full Text] [Related]
11. Non-invasive tests in prediction of liver fibrosis in chronic hepatitis B and comparison with post-antiviral treatment results.
Başar O; Yimaz B; Ekiz F; Giniş Z; Altinbaş A; Aktaş B; Tuna Y; Çoban S; Delibaş N; Yüksel O
Clin Res Hepatol Gastroenterol; 2013 Apr; 37(2):152-8. PubMed ID: 23391746
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of the FIB-4 index for non-B non-C hepatocellular carcinoma treated with surgical resection.
Nishikawa H; Osaki Y; Komekado H; Sakamoto A; Saito S; Nishijima N; Nasu A; Arimoto A; Kita R; Kimura T
Oncol Rep; 2015 Jan; 33(1):88-94. PubMed ID: 25354477
[TBL] [Abstract][Full Text] [Related]
13. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients.
Wang CC; Liu CH; Lin CL; Wang PC; Tseng TC; Lin HH; Kao JH
J Formos Med Assoc; 2015 Oct; 114(10):923-8. PubMed ID: 26279173
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic performance of non-invasive liver fibrosis scores in patients with early-intermediate hepatocellular carcinoma.
Schrecker C; Schulze F; Trojan J; Bechstein WO; Zeuzem S; Koch C
J Cancer Res Clin Oncol; 2024 Apr; 150(4):187. PubMed ID: 38602548
[TBL] [Abstract][Full Text] [Related]
15. APRI, the FIB-4 score, and Forn's index have noninvasive diagnostic value for liver fibrosis in patients with chronic hepatitis B.
Ucar F; Sezer S; Ginis Z; Ozturk G; Albayrak A; Basar O; Ekiz F; Coban S; Yuksel O; Armutcu F; Akbal E
Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1076-81. PubMed ID: 23510962
[TBL] [Abstract][Full Text] [Related]
16. The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B.
Chon YE; Jung ES; Park JY; Kim DY; Ahn SH; Han KH; Chon CY; Jung KS; Kim SU
J Clin Gastroenterol; 2012 Jul; 46(6):518-25. PubMed ID: 22688146
[TBL] [Abstract][Full Text] [Related]
17. The Diagnostic Accuracy and Clinical Utility of Three Noninvasive Models for Predicting Liver Fibrosis in Patients with HBV Infection.
Zhang Z; Wang G; Kang K; Wu G; Wang P
PLoS One; 2016; 11(4):e0152757. PubMed ID: 27050531
[TBL] [Abstract][Full Text] [Related]
18. Assessing liver fibrosis in chronic hepatitis B using MR extracellular volume measurements: Comparison with serum fibrosis indices.
Wang HQ; Jin KP; Zeng MS; Chen CZ; Rao SX; Ji Y; Fu CX; Sheng RF
Magn Reson Imaging; 2019 Jun; 59():39-45. PubMed ID: 30849483
[TBL] [Abstract][Full Text] [Related]
19. Comparing the efficiency of Fib-4, Egy-score, APRI, and GUCI in liver fibrosis staging in Egyptians with chronic hepatitis C.
Cordie A; Salama A; El-Sharkawy M; El-Nahaas SM; Khairy M; Elsharkawy A; Hassany M; Esmat G
J Med Virol; 2018 Jun; 90(6):1106-1111. PubMed ID: 29476628
[TBL] [Abstract][Full Text] [Related]
20. Development of a model based on biochemical, real‑time tissue elastography and ultrasound data for the staging of liver fibrosis and cirrhosis in patients with chronic hepatitis B.
Xu SH; Li Q; Hu YP; Ying L
Mol Med Rep; 2016 Oct; 14(4):3609-19. PubMed ID: 27573619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
